title: Changes of histaminopexy in patients with bronchial asthma and chronic urticaria after histaglobin administration.
abstract: In patients suffering from bronchial asthma and chronic urticaria, the value of histaminopexy was determined prior and after histaglobin treatment (3 injections-1 amp. at 7 days intervals). The value of histaminopexy after histaglobin treatment rised over -240% and was well correlated with the clinical effect of the therapy. These observations are considered as an "ex iuvantibus" evidence that histaminopexy may play a role in the etiopathogenesis of allergic disorders.
mesh_terms: D000328:Adult; D000368:Aged; D001249:Asthma / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D001798:Blood Proteins / Q000378:metabolism; D004338:Drug Combinations / Q000627:therapeutic use; D005260:Female; D006632:Histamine / Q000627:therapeutic use*; D006633:Histamine Antagonists / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D014581:Urticaria / Q000097:blood / Q000188:drug therapy* / Q000276:immunology; D005719:gamma-Globulins / Q000627:therapeutic use*
chemical_list: D001798:Blood Proteins; D004338:Drug Combinations; D006633:Histamine Antagonists; D005719:gamma-Globulins; C002114:Histaglobin; D006632:Histamine